Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-30 Sale |
2024-09-03 8:00 pm |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
5,985 | $137.36 | $822,100 | 33,946 (Direct) |
View |
| 2024-08-16 Purchase |
2024-08-20 08:00 am |
Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director |
37,038 | $133.8 | $4,955,728 | 292,311 (Indirect Direct) |
View |
| 2024-06-25 Sale |
2024-06-25 8:00 pm |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel |
38,957 | $161.61 | $6,296,029 | 28,879 (Direct) |
View |
| 2024-06-24 Sale |
2024-06-25 8:00 pm |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
11,757 | $163.13 | $1,917,891 | 23,613 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-06 8:09 pm |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
3,635 | $140 | $508,900 | 18,125 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-11 8:02 pm |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
15,000 | $123.25 | $1,848,795 | 22,840 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-11 8:00 pm |
Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director |
761 | $122.93 | $93,550 | 7,516 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-06 8:00 pm |
Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director |
3,135 | $122.96 | $385,480 | 6,621 (Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 8:00 pm |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
2,000 | $128.84 | $257,676 | 39,222 (Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 8:00 pm |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
1,200 | $128.3 | $153,960 | 51,614 (Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 8:00 pm |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel |
2,000 | $125.34 | $250,680 | 44,327 (Direct) |
View |
| 2023-11-03 Purchase |
2023-11-06 08:00 am |
Sarepta Therapeutics Inc. | SRPT | Barry Richard Director |
50,000 | $78.81 | $3,940,500 | 3,069,842 (Indirect Direct) |
View |
| 2023-11-03 Purchase |
2023-11-06 08:00 am |
Sarepta Therapeutics Inc. | SRPT | INGRAM DOUGLAS S President & CEO |
25,225 | $79.36 | $2,001,800 | 390,307 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-12 Option Award |
2024-09-16 8:05 pm |
2025-09-12 2034-09-12 |
Sarepta Therapeutics Inc. | SRPT | Connelly Deirdre P Director |
9,284 | $0 | 9,284 (Direct) |
View |
| 2024-09-04 Gift |
2024-09-05 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
746 | $0 | 201,093 (Direct) |
View |
| 2024-07-03 Exercise |
2024-07-08 8:00 pm |
2016-02-27 2025-02-27 |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
15,000 | $0 | 201,839 (Direct) |
View |
| 2024-07-03 Exercise |
2024-07-08 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
15,000 | $13.9 | 201,839 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel |
29,750 | $0 | 28,879 (Direct) |
View |
| 2024-06-24 Tax Withholding |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel |
2,352 | $164.64 | 28,879 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel |
11,750 | $0 | 28,879 (Direct) |
View |
| 2024-06-25 Exercise |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel |
23,500 | $62.77 | 28,879 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
6,250 | $0 | 83,891 (Direct) |
View |
| 2024-06-24 Tax Withholding |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
2,182 | $164.64 | 83,891 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
11,750 | $0 | 83,891 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
6,250 | $0 | 33,773 (Direct) |
View |
| 2024-06-24 Tax Withholding |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
2,352 | $164.64 | 33,773 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
11,750 | $0 | 33,773 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
6,250 | $0 | 51,681 (Direct) |
View |
| 2024-06-24 Tax Withholding |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
2,483 | $164.64 | 51,681 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
11,750 | $0 | 51,681 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
6,250 | $0 | 23,613 (Direct) |
View |
| 2024-06-24 Tax Withholding |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
2,352 | $164.64 | 23,613 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
6,250 | $0 | 23,613 (Direct) |
View |
Ownership |
2024-05-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
0 | $0 | 225,778 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-11 8:02 pm |
2016-02-27 2035-02-27 |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
15,000 | $0 | 22,840 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-11 8:02 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
15,000 | $13.9 | 22,840 (Direct) |
View |
| 2024-03-07 Tax Withholding |
2024-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
506 | $120.49 | 25,222 (Direct) |
View |
| 2024-03-08 Tax Withholding |
2024-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
472 | $123.14 | 25,222 (Direct) |
View |
| 2024-03-07 Tax Withholding |
2024-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
512 | $120.49 | 68,073 (Direct) |
View |
| 2024-03-08 Tax Withholding |
2024-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
909 | $123.14 | 68,073 (Direct) |
View |
| 2024-03-07 Tax Withholding |
2024-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel |
506 | $120.49 | 28,688 (Direct) |
View |
| 2024-03-08 Tax Withholding |
2024-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel |
899 | $123.14 | 28,688 (Direct) |
View |
| 2024-03-07 Tax Withholding |
2024-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
526 | $120.49 | 36,164 (Direct) |
View |
| 2024-03-08 Tax Withholding |
2024-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
1,035 | $123.14 | 36,164 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
1,389 | $125.32 | 37,725 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel |
1,734 | $125.32 | 30,093 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
522 | $125.32 | 26,200 (Direct) |
View |
| 2024-03-04 Tax Withholding |
2024-03-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
1,728 | $125.32 | 69,494 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director |
5,525 | $0 | 21,853 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director |
5,525 | $0 | 13,435 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
3,679 | $0 | 26,519 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
1,846 | $0 | 26,519 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
5,525 | $0 | 190,518 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director |
5,525 | $0 | 258,952 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
18,500 | $0 | 39,222 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
365 | $126.19 | 39,222 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director |
5,525 | $0 | 11,956 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
18,500 | $0 | 51,614 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
365 | $126.19 | 51,614 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | Barry Richard Director |
5,525 | $0 | 3,185,367 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel |
18,500 | $0 | 44,327 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel |
269 | $126.19 | 44,327 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:00 pm |
2025-03-01 2034-03-01 |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
18,500 | $0 | 83,722 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
778 | $126.19 | 83,722 (Direct) |
View |
| 2023-12-01 Tax Withholding |
2023-12-05 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
3,682 | $80.34 | 22,886 (Direct) |
View |
| 2023-11-17 Tax Withholding |
2023-11-20 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
4,508 | $82.98 | 65,751 (Direct) |
View |
| 2023-11-03 Exercise |
2023-11-06 08:00 am |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
15,000 | $29.03 | 184,993 (Direct) |
View |
| 2023-11-03 Exercise |
2023-11-06 08:00 am |
2015-02-28 2024-02-28 |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
15,000 | $0 | 184,993 (Direct) |
View |